Listen to the Audio Recording: Click here

Manufacturing quality issues are a leading cause of supply chain disruption for pharmaceuticals. The absence of aligned incentives has forced manufacturers at times to meet minimal manufacturing standards or pull out of certain markets altogether. Transparency and collaboration are key steps to addressing the risk to quality, as shared in this session by various stakeholders from the pharmaceutical supply chain. Learn how suppliers and providers are coming together through the work of the End Drug Shortages Alliance. Plus, hear the latest updates on emerging industry solutions that are exploring ways to measure elements of quality that can lead to greater resiliency in the supply chain.

Learning Objectives:

1. Examine how gaps in quality can negatively impact product availability.

2. Identify how key supply chain stakeholders including suppliers, distributors, IDNs, and GPOs are working together to achieve better transparency, achieve supply readiness and mitigate quality issues.

3. Analyze FDA’s work on the Quality Management Maturity program for pharmaceutical manufacturing sites, and how it can provide improved supply chain insights that can support providers in making informed purchasing decisions leading to enhanced product access and availability.

4. Formulate strategies for your organization can better position itself to provide better patient safety and quality of care.

Listen to the Audio Recording: Click Here

View PowerPoint: Click Here

This education session aims to equip clinical pharmacy professionals with an understanding of the various population health factors and social determinants that impact healthcare outcomes in different populations. Additionally, the session will cover topics such as health disparities, health literacy, care access, testing, diagnostics, and vaccines - providing attendees with tools to better serve diverse patient populations. This knowledge will enable clinical pharmacy professionals to better understand targeted interventions to improve health outcomes and promote health equity.

Learning objectives:

1. Develop an understanding of the social determinants of health and how they impact healthcare outcomes across a variety of populations, including vulnerable and marginalized populations.

2. Describe the impact of vaccines and diagnostics and the critical importance of community buy-in.

3. Explain the impact of the RSV virus and how vaccines contribute to population health and avoidable admissions.

4. Examine the importance of point-of-care testing/rapid diagnostics

Listen to the Audio Recording: Click Here

View PowerPoint: Click Here

Ensuring safe and correct labeling in hospital operating rooms (ORs) is among the most significant ways to reduce medication errors and protect patient safety. The session will cover the importance of proper labeling for medication and equipment to prevent errors, improve safety, and comply with regulatory requirements. Participants will learn about best practices for labeling, including technology and designs, and how to implement them in their work environments. The session will also discuss common labeling mistakes and how to avoid them.

Learning Objectives:

1. Evaluate the critical importance of safe labeling in an OR setting.

2. Assess common labeling mistakes in hospital operating rooms ORs and develop strategies to avoid them.

3. Analyze several technology and label designs and assess their effectiveness and applicability.

4. Identify the use of data in safe labeling and its contribution to improving outcomes.